Brief: Medadvisor Sees Growth Rate To Moderate In H2 As We Move Beyond U.S. Winter Months
28/02/2023 04:00
Feb 28 (Reuters) - Medadvisor Ltd MDR.AX :
* SEES RATE OF GROWTH TO MODERATE IN SECOND HALF AS WE MOVE
BEYOND
WINTER MONTHS IN U.S.
Source text for Eikon: ID:nASX3Fm3p2
Further company coverage: MDR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adheris Health
See all newsBrief: Adheris Health Posts Q3 Operating Revenue Of A$5.4M
Brief: Adheris Health Posts HY Profit From Ordinary Activities After Tax Attributable A$7.3 Million
Brief: Adheris Health Expects 30% Total Operating Cost Savings Over Two Years
Brief: Adheris Health Posts Q2 Operating Revenue A$13.7 Million
Brief: Adheris Health Says A$6.1M Holdback Consideration Received